Listing 3 - Actual negotiations

Indication:

Opioid overdose, known or suspected, for emergency use

Indication:

Epilepsy, partial-onset seizures

Indication:

Chronic Immune Thrombocytopenia

Indication:

Growth hormone deficiency

Indication:

Migraine, prevention

Indication:

Hereditary Angioedema

Indication:

Contraceptive, oral

Indication:

Follicular lymphoma (FL), Relapsed or refractory, grade 1, 2 or 3a, in adult patients after two or more lines of systemic therapy

Indication:

Diffuse large B-cell lymphoma (DLBCL) or high-grade B-cell lymphoma (HGBL), in adult patients, that is refractory to first-line chemoimmunotherapy or that relapses within 12 months of first-line chemoimmunotherapy

Indication:

Von Hippel-Lindau (VHL) disease in adult patients who require therapy for associated non-metastatic renal cell carcinoma (RCC), central nervous system (CNS) hemangioblastomas, or non-metastatic pancreatic neuroendocrine tumors (pNET), not requiring immediate surgery.